Clinical Trials in Sejong, South Korea
Locations / Sejong, South Korea
Delta Trials lists 33 clinical trials conducted in Sejong, South Korea, making it a notable site of clinical research activity. These trials addressing 57 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Sejong research landscape.
33
Total Trials
57
Conditions
2
Terminated since 2020
Browse by condition (57 total)
- Coronary artery disease 4 trialsAll Coronary artery disease trials
- All Cardiac implantable electronic device trials
- Antiphospholipid syndrome 1 trialAll Antiphospholipid syndrome trials
- Lymphedema 1 trialAll Lymphedema trials
- Angina pectoris, variant 1 trialAll Angina pectoris, variant trials
- All Anaemia associated with chronic kidney disease trials
- Osteoarthritis 1 trialAll Osteoarthritis trials
- Ovarian cancer 1 trialAll Ovarian cancer trials
- Acute coronary syndrome 1 trialAll Acute coronary syndrome trials
- Femoral artery 1 trialAll Femoral artery trials
- Parkinson's disease 1 trialAll Parkinson's disease trials
- Transient ischemic attack 1 trialAll Transient ischemic attack trials
- All Chronic total occlusion of coronary artery trials
- All Breast cancer classified as tnm stage 0-iiia trials
- All Fgf23-related hypophosphataemic rickets and osteomalacia trials
- Ischemic stroke 1 trialAll Ischemic stroke trials
- Germline mutation abnormality 1 trialAll Germline mutation abnormality trials
- Coronary artery stenosis 1 trialAll Coronary artery stenosis trials
- Benign breast disease 1 trialAll Benign breast disease trials
- Breast neoplasms 1 trialAll Breast neoplasms trials